Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice

Molecular Psychiatry
J C O'ConnorR Dantzer

Abstract

Although elevated activity of the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) has been proposed to mediate comorbid depression in inflammatory disorders, its causative role has never been tested. We report that peripheral administration of lipopolysaccharide (LPS) activates IDO and culminates in a distinct depressive-like behavioral syndrome, measured by increased duration of immobility in both the forced-swim and tail suspension tests. Blockade of IDO activation either indirectly with the anti-inflammatory tetracycline derivative minocycline, that attenuates LPS-induced expression of proinflammatory cytokines, or directly with the IDO antagonist 1-methyltryptophan (1-MT), prevents development of depressive-like behavior. Both minocycline and 1-MT normalize the kynurenine/tryptophan ratio in the plasma and brain of LPS-treated mice without changing the LPS-induced increase in turnover of brain serotonin. Administration of L-kynurenine, a metabolite of tryptophan that is generated by IDO, to naive mice dose dependently induces depressive-like behavior. These results implicate IDO as a critical molecular mediator of inflammation-induced depressive-like behavior, probably through the catabolism of tryptophan alon...Continue Reading

Associated Clinical Trials

References

Nov 1, 1973·Pharmakopsychiatrie, Neuro-Psychopharmakologie·I P Lapin
Mar 4, 1996·Brain Research·R Yirmiya
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·J YrjänheikkiJ Koistinaho
Mar 15, 2000·Reviews in the Neurosciences·R D Porsolt
Nov 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·Y DuS M Paul
Feb 20, 2002·Trends in Neurosciences·Jan Pieter KonsmanRobert Dantzer
Apr 3, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Lucile CapuronAndrew H Miller
Aug 6, 2002·Journal of Neuroimmunology·Kenichi SakuraiGene M Shearer
Oct 29, 2002·Brain, Behavior, and Immunity·Bernhard WidnerDietmar Fuchs
Mar 5, 2003·Brain, Behavior, and Immunity·Keith W KelleySuzanne R Broussard
Mar 5, 2003·Brain, Behavior, and Immunity·Lucile Capuron, Robert Dantzer
Dec 4, 2003·Molecular Psychiatry·L BooijW J Riedel
Mar 17, 2004·Current Opinion in Pharmacology·Robert Schwarcz
Jun 23, 2004·Advances in Experimental Medicine and Biology·Gilles J GuilleminBruce J Brew
Sep 28, 2004·Nature Medicine·Su K SeoByoung S Kwon
Oct 2, 2004·Nature Reviews. Immunology·Andrew L Mellor, David H Munn
Apr 28, 2005·JAMA : the Journal of the American Medical Association·M Christine ZinkSheila Barber
Jun 9, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Erik KwidzinskiIngo Bechmann
Aug 9, 2005·Biological Psychiatry·Dwight L EvansWilliam J Valvo
Sep 27, 2005·Current Neurovascular Research·Hajnalka NémethLászló Vécsei
Feb 3, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chong-Bin ZhuWilliam A Hewlett
Mar 24, 2006·Pharmacotherapy·Hazem F ElewaSusan C Fagan

❮ Previous
Next ❯

Citations

Jul 26, 2011·Journal of Neural Transmission·Vilma GabbayLeonard Liebes
Dec 1, 2012·International Psychogeriatrics·Chantal J SlorJos F M de Jonghe
Feb 27, 2013·Molecular Psychiatry·W D TaylorG S Alexopoulos
Sep 10, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Chong-Bin ZhuWilliam A Hewlett
Sep 16, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ebrahim HaroonAndrew H Miller
Nov 11, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Patricia A ZunszainCarmine M Pariante
Feb 23, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marcia D McNuttDominique L Musselman
May 30, 2012·Nature Reviews. Clinical Oncology·Robert DantzerCharles S Cleeland
Sep 21, 2010·Nature Reviews. Neuroscience·Liqun LuoA D Craig
Dec 14, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jonathan P GodboutRodney W Johnson
Sep 1, 2009·Integrative and Comparative Biology·Michael A GalicQuentin J Pittman
Jul 4, 2012·The Journal of Clinical Investigation·Hyangin KimJianren Mao
May 15, 2008·Journal of Neuroinflammation·Christopher J HenryJonathan P Godbout
Dec 21, 2010·Journal of Neuroinflammation·Angela W CoronaJonathan P Godbout
Dec 12, 2012·The Journal of Experimental Biology·Robert H McCusker, Keith W Kelley
Jul 28, 2011·Neuropsychiatric Disease and Treatment·David M ChristmasSimon Jc Davies
Jul 4, 2012·Indian Journal of Human Genetics·Anand TamatamAmarinder Singh Bawa
Jul 31, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jonathan SavitzRobert Dantzer
Oct 16, 2013·Molecular Psychiatry·A Aguilar-VallesG N Luheshi
May 6, 2014·Cellular and Molecular Neurobiology·Yan-Yan FuYuan-Jian Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here